A new phase 3 clinical trial found that Eli Lilly’s weight loss drug Zepbound resulted in significantly greater weight loss than Wegovy.
Read the full post on Becker's Hospital Review | Healthcare News & Analysis
Zepbound outperforms Wegovy for weight loss: Study
